Assembly Biosciences, Inc. (ASMB)
NASDAQ: ASMB · Real-Time Price · USD
27.27
+0.53 (1.98%)
At close: Aug 11, 2026, 4:00 PM EDT
27.27
0.00 (0.00%)
After-hours: Aug 11, 2026, 4:20 PM EDT
Assembly Biosciences Market Cap
Assembly Biosciences has a market cap or net worth of $524.97 million as of August 11, 2026. Its market cap has increased by 252.09% in one year.
Market Cap
524.97M
Enterprise Value
300.86M
1-Year Change
252.09%
Ranking
Category
Stock Price
$27.27
ChartMarket Cap Chart
Since December 17, 2010, Assembly Biosciences's market cap has increased from $40.20M to $524.97M, an increase of 1,205.90%. That is a compound annual growth rate of 17.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 424.00M | -21.17% |
| Dec 31, 2025 | 537.90M | 436.29% |
| Dec 31, 2024 | 100.30M | 86.09% |
| Dec 29, 2023 | 53.90M | -14.98% |
| Dec 30, 2022 | 63.40M | -43.14% |
| Dec 31, 2021 | 111.50M | -44.19% |
| Dec 31, 2020 | 199.80M | -62.51% |
| Dec 31, 2019 | 532.90M | -7.48% |
| Dec 31, 2018 | 576.00M | -26.83% |
| Dec 29, 2017 | 787.20M | 276.11% |
| Dec 30, 2016 | 209.30M | 61.75% |
| Dec 31, 2015 | 129.40M | 54.60% |
| Dec 31, 2014 | 83.70M | 5.02% |
| Dec 31, 2013 | 79.70M | 185.66% |
| Dec 31, 2012 | 27.90M | -71.93% |
| Dec 30, 2011 | 99.40M | 135.55% |
| Dec 31, 2010 | 42.20M | 4.98% |
| Dec 17, 2010 | 40.20M | - |
View and export this data all the way back to 2010. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ginkgo Bioworks Holdings | 536.70M |
| Adlai Nortye | 531.20M |
| Relmada Therapeutics | 526.95M |
| Evommune | 510.99M |
| Eikon Therapeutics | 502.95M |
| Entera Bio | 496.92M |
| Valneva SE | 496.81M |
| ProKidney | 495.38M |